english.prescrire.org > Spotlight > Archives : 2022 > EMA's response to Prescrire's analysis of EMA's transparency policy over the last 10 years

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2022 : 1 | 30 | 60

EMA's response to Prescrire's analysis of EMA's transparency policy over the last 10 years

The reply by the European Medicines Agency's Executive Director, in response to Prescrire's critique of the Agency's transparency policy, with comments added by Prescrire, appears in the September 2022 issue of Prescrire International.

Prescrire sent a copy of its article "European Medicines Agency: transparency policy marred by too many failings" (available >HERE) to Emer Cooke, Executive Director of the European Medicines Agency.

In this article, Prescrire calls for an official inquiry in order to analyse the causes of EMA's failings, and to enable Members of the European Parliament to take appropriate steps.

Emer Cooke's reply (20 May 2022) appears in the September 2022 issue of Prescrire International, with comments added by Prescrire.

Full text available for free download below.

©Prescrire 1 September 2022

Source: "Queries and comments. EMA's response to Prescrire's analysis of EMA's transparency policy over the last 10 years" Prescrire International 2022; 31 (240): 220-222. Free.

Enjoy full access to Prescrire International, and support independent information
Share
Share on Facebook Share on Twitter


For more information:

"European Medicines Agency:
insufficient transparency"
(May 2022)
Free

"The EMA is withholding
too much information"
(May 2022)
Free


See also:

"Transparent, independent
health authorities”
Advancing healthcare
policy
Free

Numerous other texts
available via the "Search"
function, using the
keyword "EMA"
Search


Read more:

All the subjects in
Prescrire's Spotlight
Free >